STOCK TITAN

Morphic to Participate in Jefferies IBD Therapeutics Summit

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Morphic Therapeutic (Nasdaq: MORF) announced participation in a fireside chat at the Jefferies Virtual Next Generation IBD Therapeutics Summit on October 19, 2021, at 3:15 p.m. ET. The event will showcase Morphic's leadership team discussing advancements in oral integrin therapies for serious chronic diseases, including autoimmune and cardiovascular conditions. A live webcast will be available on the company’s investor website, with an archived replay accessible post-event. Morphic is advancing its pipeline through collaborations with AbbVie, Janssen, and Schrödinger.

Positive
  • None.
Negative
  • None.

WALTHAM, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that members of the Morphic leadership team are scheduled to take part in a fireside chat at the Jefferies Virtual Next Generation IBD Therapeutics Summit on October 19, 2021 at 3:15 p.m. ET.

A live webcast of the Jefferies fireside chat will be available on the Investor section of Morphic’s website at www.morphictx.com. An archived replay will be available on the company’s website following the conference.

About Morphic Therapeutic
Morphic Therapeutic is a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis and cancer. In collaboration with AbbVie, Janssen, and Schrödinger, Morphic is advancing its pipeline and discovery activities using its proprietary MInT technology platform which leverages the Company’s unique understanding of integrin structure and biology. For more information, visit www.morphictx.com.

Contacts
Morphic Therapeutic
Chris Erdman
chris.erdman@morphictx.com
617.686.1718

Media Contact
Tom Donovan, Ten Bridge Communications
tom@tenbridgecommunications.com
857.559.3397


FAQ

What event is Morphic Therapeutic participating in on October 19, 2021?

Morphic Therapeutic will participate in the Jefferies Virtual Next Generation IBD Therapeutics Summit.

What time is Morphic's fireside chat scheduled for?

The fireside chat is scheduled for 3:15 p.m. ET on October 19, 2021.

Where can I watch the live webcast of Morphic's fireside chat?

The live webcast will be available on Morphic's investor section of their website.

What topics will Morphic discuss at the Jefferies Summit?

Morphic will discuss advancements in oral integrin therapies for chronic diseases.

Who are Morphic's collaborators in advancing its pipeline?

Morphic collaborates with AbbVie, Janssen, and Schrödinger.

Morphic Holding, Inc.

NASDAQ:MORF

MORF Rankings

MORF Latest News

MORF Stock Data

2.86B
40.99M
17.13%
91.02%
3.78%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
WALTHAM